Published in Schweiz Med Wochenschr on January 30, 1993
Preventable causative factors leading to hospital admission with decompensated heart failure. Heart (1998) 4.92
Cost effective management programme for heart failure reduces hospitalisation. Heart (1998) 3.39
[Telemonitoring in chronic heart failure patients. Which diagnostic finding prevents hospital readmission?]. Herzschrittmacherther Elektrophysiol (2005) 0.79
How do changes in lifestyle complement medical treatment in heart failure? Br Heart J (1994) 0.79
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum (1996) 6.88
Elevation of troponin I in sepsis and septic shock. Intensive Care Med (2001) 3.47
Myopathy as possible side-effect of cyclosporin. Lancet (1989) 3.25
Sequence heterogeneity of the eae gene and detection of verotoxin-producing Escherichia coli using serotype-specific primers. Epidemiol Infect (1994) 2.70
Importance of dural ectasia in phenotypic assessment of Marfan's syndrome. Lancet (1999) 2.20
Probing protein-protein interactions in real time. Nat Struct Biol (2000) 2.12
[Osteosynthesis of the temporal articular tubercle]. Rev Stomatol Chir Maxillofac (2007) 1.91
Cells involved in the immune response. IV. The response of normal and immune rabbit bone marrow and lymphoid tissue lymphocytes to antigens in vitro. J Exp Med (1968) 1.89
Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience (2008) 1.75
Nifedipine in hypertensive emergencies. Br Med J (Clin Res Ed) (1983) 1.75
Absolute pulse energy measurements of soft x-rays at the Linac Coherent Light Source. Opt Express (2014) 1.73
A surface active protein involved in aerial hyphae formation in the filamentous fungus Schizophillum commune restores the capacity of a bald mutant of the filamentous bacterium Streptomyces coelicolor to erect aerial structures. Mol Microbiol (1998) 1.71
Decreased Beta-adrenoreceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension (1980) 1.69
A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH. Eur Heart J (1999) 1.66
Cement leakage during vertebroplasty: an underestimated problem? Eur Spine J (2005) 1.64
A prospective randomized trial comparing stenting to internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis: the SIMA trial. Stenting vs Internal Mammary Artery. Mayo Clin Proc (2000) 1.58
The acrocallosal syndrome in sisters. Clin Genet (1986) 1.55
Pulsed-field gel electrophoresis for epidemiologic studies of Campylobacter hyointestinalis isolates. J Clin Microbiol (1992) 1.55
Single and multiple strain colonization in patients with Helicobacter pylori-associated gastritis: detection by macrorestriction DNA analysis. J Infect Dis (1994) 1.54
Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet (1995) 1.51
Cells involved in the immune response. VI. The immune response to red blood cells in irradiated rabbits after administration of normal, primed, or immune allogeneic rabbit bone marrow cells. J Exp Med (1969) 1.48
Endomyocardial biopsy in cardiac transplant recipients using the femoral venous approach. Am J Cardiol (1990) 1.46
Emergency stenting for acute occlusion after coronary balloon angioplasty. Circulation (1988) 1.45
Simple point-of-care risk stratification in acute coronary syndromes: the AMIS model. Heart (2008) 1.45
[Staging laparoscopy in Hodgkin's disease. A valid alternative to staging laparotomy]. Dtsch Med Wochenschr (1993) 1.44
The use of Poller screws as blocking screws in stabilising tibial fractures treated with small diameter intramedullary nails. J Bone Joint Surg Br (1999) 1.44
Importance of an individually programmed atrioventricular delay at rest and on work capacity in patients with dual chamber pacemakers. Pacing Clin Electrophysiol (1994) 1.41
A comparison of quality-of-life in patients with dual chamber pacemakers and individually programmed atrioventricular delays. Pacing Clin Electrophysiol (1996) 1.41
The use of radiolabelled human serum albumin and SPECT/MRI co-registration to study inflammation in the cavernous sinus of cluster headache patients. Cephalalgia (2006) 1.41
The impact of statin treatment on presentation mode and early outcomes in acute coronary syndromes. Cardiology (2007) 1.40
[Cardiac interventions in Switzerland 1992. PTCA and Fibrinolysis Work Group of the Swiss Cardiology Association]. Schweiz Med Wochenschr (1994) 1.39
[Headache, hypertension]. Schweiz Rundsch Med Prax (1991) 1.38
Prolonged heparin after uncomplicated coronary interventions: a prospective, randomized trial. Am Heart J (1998) 1.38
4-Chloro-m-cresol, a potent and specific activator of the skeletal muscle ryanodine receptor. Biochim Biophys Acta (1996) 1.29
The response of leucocytes of agammaglobulinaemia subjects to phythohaemagglutinin and anti-immunoglobulin antiserum. Clin Exp Immunol (1969) 1.29
Ultrasound-guided compression repair for treatment of femoral artery pseudoaneurysm: acute and follow-up results. Cathet Cardiovasc Diagn (1996) 1.27
Phosphorylation of serine 2843 in ryanodine receptor-calcium release channel of skeletal muscle by cAMP-, cGMP- and CaM-dependent protein kinase. Biochim Biophys Acta (1993) 1.24
H2-forming methylenetetrahydromethanopterin dehydrogenase, a novel type of hydrogenase without iron-sulfur clusters in methanogenic archaea. Eur J Biochem (1992) 1.24
High agreement on family affluence between children's and parents' reports: international study of 11-year-old children. J Epidemiol Community Health (2008) 1.23
Maternal weight and pregnancy complications. Am J Obstet Gynecol (1985) 1.23
Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure. Circulation (1998) 1.22
Trauma care in Germany. Injury (2003) 1.16
Seasonality of weather and tree phenology in a tropical evergreen mountain rain forest. Int J Biometeorol (2006) 1.16
The role of bone marrow in the immune response. Adv Immunol (1970) 1.16
Cells involved in the immune response. XXII. The demonstration of thymus-specific antigens in the rabbit. Immunology (1972) 1.15
Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study. Ann Rheum Dis (2007) 1.15
The variation in response of human peripheral lymphocytes to phytohemagglutinin in vitro. Int Arch Allergy Appl Immunol (1967) 1.15
A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies. Invest New Drugs (2006) 1.15
Intravascular stenting for stenosis of aortocoronary venous bypass grafts. J Am Coll Cardiol (1989) 1.15
Photoelectric effect at ultrahigh intensities. Phys Rev Lett (2007) 1.13
Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12
Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11
Similarity of primary radical pair recombination in photosystem II and bacterial reaction centers. FEBS Lett (1993) 1.10
Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV. Phys Rev Lett (2013) 1.08
Functional magnetic resonance imaging with intermolecular multiple-quantum coherences. Magn Reson Imaging (2000) 1.07
Improvement of pain and function after arthroscopy and arthrocentesis of the temporomandibular joint: a comparative study. J Craniomaxillofac Surg (2000) 1.06
Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at sqrt(s(NN)) = 2.76 TeV. Phys Rev Lett (2011) 1.05
Acute and chronic sympathetic reflex activation and antihypertensive response to nifedipine. J Am Coll Cardiol (1986) 1.05
Effects of antihypertensive treatment on cerebral perfusion. Am J Med (1987) 1.04
Computer-assisted analysis of lower limb geometry: higher intraobserver reliability compared to conventional method. Comput Aided Surg (2006) 1.04
Cells involved in the immune response. I. The response of normal rabbit bone marrow cells to antigens in vitro. Int Arch Allergy Appl Immunol (1968) 1.04
Absorption and excretion of furosemide-S35 in human subjects. Proc Soc Exp Biol Med (1966) 1.03
Structural proteins involved in emergence of microbial aerial hyphae. Fungal Genet Biol (1999) 1.02
Epicardial, biatrial synchronous pacing for prevention of atrial fibrillation after cardiac surgery. Pacing Clin Electrophysiol (1999) 1.02
Endothelium-dependent relaxation of porcine pulmonary arteries via 5-HT1C-like receptors. Naunyn Schmiedebergs Arch Pharmacol (1993) 1.01
Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm. Am J Cardiol (1986) 1.00
Cells involved in the immune response. 3. Responsiveness in antigens of a lymphocyte-rich fraction of normal rabbit bone marrow. Int Arch Allergy Appl Immunol (1968) 0.99
Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease. Circulation (1998) 0.99
Microcirculation of the ankle after Cryo/Cuff application in healthy volunteers. Int J Sports Med (2006) 0.98
Long-term follow-up of the first 56 patients treated with intracoronary self-expanding stents (the Lausanne experience). Am J Cardiol (1991) 0.98
Production of muons from heavy flavor decays at forward rapidity in pp and Pb-Pb collisions at sqrt[s(NN)]=2.76 TeV. Phys Rev Lett (2012) 0.98
[The influence of transportation mode on mortality in polytraumatized patients. An analysis based on the German Trauma Registry]. Unfallchirurg (2007) 0.98
Albumin-mediated regulation of cellular glutathione and nuclear factor kappa B activation. Am J Respir Crit Care Med (2000) 0.97
Cells involved in the immune response. XV. The organ source of the antigen reactive cells in the normal rabbit. Int Arch Allergy Appl Immunol (1970) 0.97
[Posterior dynamic stabilization as an alternative for dorso-ventral fusion in spinal stenosis with degenerative instability]. Z Orthop Ihre Grenzgeb (2003) 0.97
Enhanced in vivo IgE production and T cell polarization toward the type 2 phenotype in association with indoor exposure to VOC: results of the LARS study. Int J Hyg Environ Health (2001) 0.96
Cells involved in the immune response. 13. The nature of the cellular interactions relating antibody formation and immunologic tolerance: a unified hypothesis. Proc Natl Acad Sci U S A (1969) 0.96
Review article: percutaneous endoscopic gastrostomy in infants and children. Aliment Pharmacol Ther (2010) 0.96
Basement membrane specific antisera produced to solubilized tissue fractions. Immunology (1966) 0.96
Pharmacological survey of recombinant hirudin. Pharmazie (1988) 0.95
Inhibition of phosphorylase-a by fructose-1-phosphate, alpha-glycerophosphate and fructose-1,6-diphosphate: explanation for fructose-induced hypoglycaemia in hereditary fructose intolerance and fructose-1,6-diphosphatase deficiency. Eur J Clin Invest (1973) 0.94
The in vitro blastogenic response of lymphocytes of ragweed-sensitive individuals. J Allergy (1968) 0.94
Human toxicity of various oximes. 2-Pyridine aldoxime methyl chloride, its methane sulfonate salt, and 1,1'-trimethylenebis-(4-formylpyridinium chloride). Arch Environ Health (1967) 0.93
Identification of the major fibroblast growth factors released spontaneously in inflammatory arthritis as platelet derived growth factor and tumour necrosis factor-alpha. Clin Exp Immunol (1991) 0.93
Centrality dependence of the charged-particle multiplicity density at midrapidity in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2011) 0.93
Colour coded duplex sonography in suspected deep vein thrombosis of the leg. BMJ (1990) 0.93
Relative risk analysis of angiographic predictors of restenosis within the coronary Wallstent. Circulation (1991) 0.93
[Rhabdomyolysis after administration of diclofenac]. Unfallchirurg (2005) 0.92
Factors influencing the hypotensive effects of calcium antagonists. Hypertension (1983) 0.92
Biological properties of NSILA-S. Adv Metab Disord (1975) 0.92
WHODAS II with people after stroke and their relatives. Disabil Rehabil (2009) 0.92
Endothelin and calcium antagonists in the skin microcirculation of patients with coronary artery disease. Circulation (1996) 0.92